Postmenopausal hormone therapy: Is it useful for coronary prevention?

Cardiology Clinics

Volumn 16, Issue 1, 1998, Pages 17-25

  Wenger, N K ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; SEX HORMONE;

CORONARY ARTERY DISEASE; CORONARY RISK; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; HEART PROTECTION; HIGH RISK POPULATION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; POSTMENOPAUSE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK BENEFIT ANALYSIS; VASCULAR ENDOTHELIUM;

EID: 0031911357     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70380-5     Document Type: Article

References (57)

1. American College of Physicians Guidelines for counseling postmenopausal women about preventive hormone therapy Ann Intern Med 117 1992 1038
2. T.L. Bush E. Barrett-Connor L.D. Cowan Cardiovascular mortality and noncontraceptive use of estrogen in women: Results from the Lipid Research Clinics Program Follow-up Study Circulation 75 1987 1102
3. N.F. Col M.H. Eckman R.H. Karas Patient-specific decisions about hormone replacement therapy in postmenopausal women JAMA 277 1997 1140
4. G.A. Colditz S.E. Hankinson D.J. Hunter The use of estrogens and progestins and the risk of breast cancer in postmenopausal women N Engl J Med 332 1995 1589
5. P. Collins G.M.C. Rosano P.M. Sarrel 17β-estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease Circulation 92 1995 24
6. E. Daly M.P. Vessey M.M. Hawkins Increased risk of venous thromboembolism in hormone replacement therapy users Lancet 348 1996 977
7. E.D. Eaker J.H. Chesebro F.M. Sacks Cardiovascular disease in women Circulation 88 1993 1999
8. B. Ettinger G.D. Friedman T. Bush Reduced mortality associated with long-term postmenopausal estrogen therapy Obstet Gynecol 87 1996 6
9. Panel Expert Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (ATP-II) JAMA 269 1993 3015
10. M. Falkeborn I. Persson H.-O. Adams The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement Br J Obstet Gynaecol 99 1992 821
11. A.R. Folsom P.J. Mink T.A. Sellers Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women Am J Public Health 85 1995 1128
12. O.C.E. Gebara M.A. Mittleman P. Sutherland Association between increased estrogen status and increased fibrinolytic potential in the Framingham Offspring Study Circulation 91 1995 1952
13. D. Grady T. Gebretsadik K. Kerlikowke Hormone replacement therapy and endometrial cancer risk: A metaanalysis Obstet Gynecol 85 1995 304
14. D. Grady S.M. Rubin D.B. Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 117 1992 1016
15. F. Grodstein M. Stampfer The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women Prog Cardiovasc Dis 38 1995 199
16. F. Grodstein M.J. Stampfer G.A. Colditz Postmenopausal hormone therapy and mortality N Engl J Med 336 1997 1769
17. F. Grodstein M.J. Stampfer S.Z. Goldhaber A prospective study of exogenous hormones and risk of pulmonary embolism in women Lancet 348 1996 983
18. F. Grodstein M.J. Stampfer J.E. Manson Postmenopausal estrogen and progestin use and the risk of cardiovascular disease N Engl J Med 335 1996 453
19. H.W. Gruchow A.J. Anderson J.J. Barboriak Postmenopausal use of estrogen and occlusion of coronary arteries Am Heart J 154 1988 954
20. B.E. Henderson A. Paganini-Hill R.K. Ross Decreased mortality in users of estrogen replacement therapy Arch Intern Med 151 1991 75
21. B.E. Henderson A. Paganini-Hill R.K. Ross Estrogen replacement therapy and protection from acute myocardial infarction Am J Obstet Gynecol 159 1988 312
22. D.R. Holmes Jr R. Holubkov R.E. Vlietstra Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry J Am Coll Cardiol 12 1988 1149
23. M.K. Hong P.A. Romm K. Reagan Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women Am J Cardiol 69 1992 176
24. K. Hunt M. Vessey K. McPherson Mortality in a cohort of long-term users of hormone replacement therapy: An updated analysis Br J Obstet Gynaecol 97 1990 1080
25. H. Jick L.F. Derby M.W. Myers Risk of hospital admission for idiopathic venous thrombolism among users of postmenopausal estrogens Lancet 348 1996 981
26. C. Kawas S. Resnick A. Morrison A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging Neurology 48 1997 1517
27. S.S. Khan S. Nessim R. Gray Increased mortality of women in coronary artery bypass surgery: Evidence for referral bias Ann Intern Med 112 1990 561
28. S.C. Kim O'Keefe J.H. Jr R.W. Ligon Estrogen improves long-term outcome after coronary angioplasty Circulation 92 suppl I 1995 I-674
29. R.H. Knopp X. Zhu B. Bonet Effects of estrogens on lipoprotein metabolism and cardiovascular disease in women Atherosclerosis 110 suppl 1994 S83
30. D.J. Lerner W.B. Kannel Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham population Am Heart J 113 1986 383
31. R.A. Lobo J.H. Pickar R.A. Wild Metabolic impact of adding medroxyprogesterone acetate to conjugated estrogen therapy in postmenopausal women Obstet Gynecol 84 1994 987
32. T.A. Manolio C.D. Furberg L. Shemanski Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women Circulation 88 pt 1 1993 2163
33. J.E. Manson Postmenopausal hormone therapy and atherosclerotic disease Am Heart J 128 1994 1337
34. C. Maynard P.E. Litwin J.S. Martin Gender differences in the treatment and outcome of acute myocardial infarction: Results from the Myocardial Infarction Triage and Intervention Registry Arch Intern Med 152 1992 972
35. C. Maynard W.D. Weaver Treatment of women with acute MI: New findings from the MITI Registry J Myocard Ischemia 4 1992 27
36. K.F. McFarland M.E. Boniface C.A. Hornung Risk factors and noncontraceptive estrogen use in women with and without coronary disease Am Heart J 117 1989 1209
37. Medical Research Council's General Practice Research Framework: Randomized comparison of estrogen versus estrogen plus progestogen hormone replacement therapy in women with hysterectomy BMJ 312 1996 473
38. H.D. Movsowitz R.P. Emmi A. Manginas Directional coronary atherectomy in women compared with men Clin Cardiol 16 1994 597
39. B.M. Psaty S.R. Heckbert D. Atkins The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women Arch Intern Med 154 1994 1333
40. S.E. Reis S.T. Gloth R.S. Blumenthal Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women Circulation 89 1994 52
41. J.E. Rossouw Estrogens for prevention of coronary heart disease: Putting the brakes on the bandwagon Circulation 94 1996 2982
42. S.A. Samaan M.H. Crawford Estrogen and cardiovascular function after menopause J Am Coll Cardiol 26 1995 1403
43. J. Schwartz R. Freeman W. Frishman Clinical pharmacology of estrogens: Cardiovascular actions and cardioprotective benefits of replacement therapy in postmenopausal women J Clin Pharmacol 35 1995 314
44. M.J. Stampfer G.A. Colditz Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence Prev Med 20 1991 47
45. M.J. Stampfer G.A. Colditz W.C. Willett Postmenopausal estrogen therapy and cardiovascular disease: Ten-year follow-up from the Nurses' Health Study N Engl J Med 325 1991 756
46. J.L. Stanford N.S. Weiss L.F. Voight Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women JAMA 274 1995 137
47. J.M. Sullivan Estrogen replacement Circulation 94 1996 2699
48. J.M. Sullivan F. El-Zeky R. Vander Zwaag Estrogen replacement therapy after coronary artery bypass surgery: Effect on survival J Am Coll Cardiol 23 1994 7A
49. J.M. Sullivan R. Vander Zwaag J.P. Hughes Estrogen replacement and coronary artery disease: Effect on survival in postmenopausal women Arch Intern Med 150 1990 2557
50. J.M. Sullivan R. Vander Zwaag G.F. Lemp Postmenopausal estrogen use and coronary atherosclerosis Ann Intern Med 108 1988 358
51. S.G. Thompson T.W. Meade G. Greenberg The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women J Epidemiol Community Health 43 1989 173
52. F.K. Welty M.A. Mittleman R.W. Healy Similar results of percutaneous transluminal coronary angioplasty for women and men with postmyocardial infarction ischemia J Am Coll Cardiol 23 1994 35
53. N.K. Wenger Gender, coronary artery disease, and coronary bypass surgery Ann Intern Med 112 1990 557
54. N.K. Wenger L. Speroff B. Packard Cardiovascular health and disease in women N Engl J Med 329 1993 247
55. J.K. Williams M.R. Adams H.S. Klopfenstein Estrogen modulates responses of atherosclerotic coronary arteries Circulation 81 1990 1680
56. Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial JAMA 273 1995 199
57. J.H. Wuerst Jr T.J. Dry J.E. Edwards The degree of coronary atherosclerosis in bilaterally oophorectomized women Circulation 7 1953 801